JBS N.V. Earnings Call Transcripts
Fiscal Year 2025
-
Record annual revenue and net income growth were driven by strong global protein demand, diversified operations, and margin expansion in key regions. Robust cash flow, disciplined capital allocation, and a strengthened balance sheet support continued investment and shareholder returns.
-
Record Q3 net sales and strong global demand drove robust results, with all segments showing growth. U.S. beef margins remain pressured by tight supply, while Brazil and Australia benefit from export demand. Leverage is stable, and expansion projects and lifted export bans support future growth.
-
Record Q2 results with $21B in sales and $1.8B adjusted EBITDA, driven by strong poultry and prepared foods. U.S. beef margins remain pressured, but pork and Australia segments show resilience. Capital allocation includes $1.2B in dividends and a $400M buyback.
-
First-quarter net sales rose 8.5% and net profit jumped 50.5% year-over-year, with strong results in poultry, pork, and Australia offsetting US beef margin pressures from high cattle prices and tariffs. Leverage improved to 1.99x EBITDA, and $789 million in dividends were approved.
Fiscal Year 2024
-
Record 2024 results with $77B revenue and $1.8B net income, driven by strong multi-protein performance and global diversification. Leverage fell to 1.89x, free cash flow surged, and major investments and shareholder returns were executed.
-
Q3 2024 saw record revenue and EBITDA, strong free cash flow, and margin expansion across key segments. Leverage improved to 2.15x, with robust dividend payouts and a positive outlook supported by innovation and global demand.
-
Q2 2024 saw net revenue of $19.3B, EBITDA margin of 9.8%, and strong free cash flow, with leverage dropping to 2.77x. Poultry and pork led performance, while investments and operational improvements drove margin gains across segments.